← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #894 OF 1,000 MOST-CITED

Written procedures - product received; packaging, labeling

FDA cited this observation 21 times across 21 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods21
BY FISCAL YEAR
FY20241
FY20233
FY20222
FY20211
FY20201
FY20192
FY20184
FY20174
FY20163

How FDA worded it — real examples

You did not establish and follow written procedures for the requirements for product received for packaging or labeling as a dietary supplement.

Txsyn Int. LLC · San Antonio, Texas · Foods · 2023-11-14

You did not establish and follow written procedures for the requirements for product received for packaging or labeling as a dietary supplement.

Bio-Life Kali 3 Limited Liability Company · Baldwin Park, California · Foods · 2023-04-27

You did not establish written procedures for the requirements for product received for packaging or labeling as a dietary supplement.

Herbal Essentials Inc. · Edison, New Jersey · Foods · 2023-01-30

You did not establish and follow written procedures for the requirements for product received for packaging or labeling as a dietary supplement.

Simplicity Filling Systems, LLC · Plantation, Florida · Foods · 2023-01-13

You did not establish written procedures for the requirements for product received for packaging or labeling as a dietary supplement.

ANFALA, INC. · Sarasota, Florida · Foods · 2022-05-20

You did not establish written procedures for the requirements for product received for packaging or labeling as a dietary supplement.

Intelligent Drinking LLC · New Braunfels, Texas · Foods · 2021-10-14

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharmaceutical quality systemFood industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →